Treatment of HIV-1 positive adults with antiretroviral therapy (E-Learning Module 4)

Participation is for BHIVA Members only.  If you are not a member of BHIVA, please click here to find out more about Membership.

This module is based on the British HIV Association guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2012.

Objectives of the package and educational value to the user

Participants are expected to be familiar with or have read the British HIV Association guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy (2012). Upon completion of this activity, participants will have an understanding of:

  • the diagnosis and monitoring of hepatitis infection in HIV infected persons
  • the management principles for assessing the significance, severity and treatment of hepatitis infection and its complications in HIV infected persons
  • the principles and management of drug-drug interactions between HIV and hepatitis therapies and their individual toxicities

-  It is expected that it should take each participant approximately 3 hours to study the guidelines and answer all 20 questions. 
-  There is a time limit of 40 minutes to answer all questions once you have started. 
-  There is also a form for you to provide feedback at the end, which must be completed within this time.
-  Once you have completed the feedback form, you will immediately be taken to a page showing your results.
-  The pass rate is 65%.

 

In order to obtain RCP CPD accreditation for BHIVA e-learning modules, participants are now requested to access the RCP self-accreditation site and enter their CPD points (3 hours = 3 CPD points).

 

Please also ensure that Pop-ups are not being blocked by your browser before you begin.
 

  Click here to download and study the guidelines

Click here to begin (40 minutes to answer 20 Questions)